Related Experiment Video

Updated: May 9, 2025

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

6.1K

The antimicrobial resistance cube: a framework for identifying policy gaps and driving action

Elias Mossialos1, Kevin Outterson2, Sally Davies3

  • 1LSE Health, Department of Health Policy, London School of Economics and Political Science, London WC2A 2AE, UK.

Lancet (London, England)
|May 3, 2025
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
06:54

Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics

Published on: July 19, 2024

897
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

Related Experiment Videos

Last Updated: May 9, 2025

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

6.1K
Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
06:54

Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics

Published on: July 19, 2024

897
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

51.9K
Overview
51.9K

Articles linked to this work by shared authors, journal, and citation graph.

Lessons learned for the Independent Panel for Evidence for Action against AMR from previous international science panels: stakeholder views from the 2025 Lagos Workshop.

The Lancet. Microbe·2026

Artificial intelligence, intellectual property, and human rights: mapping the legal landscape in European health systems.

npj health systems·2026

A systematic review of economic evidence of artificial intelligence in healthcare.

Health policy (Amsterdam, Netherlands)·2026

Artificial intelligence needs better health systems to reduce inequalities.

NPJ digital medicine·2026

Global norms, local institutions: a controlled comparative case study of WHO essential medicines policy adoption in Eastern Europe.

Globalization and health·2026

Mind the governance gap: a one health scoping review of national AMR performance indicators.

npj antimicrobials and resistance·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

'They (researchers) don't have to justify their presence, why do we have to justify ours?': The political economy of community advisory boards in tuberculosis research.

Social science & medicine (1982)·2026

Measuring trust in public health authorities in the United States: An item response theory analysis.

PloS one·2026

Kidney Transplantation from Hepatitis C-Positive Donors in the Direct-Acting Antiviral Era.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Policy in implementation science: Considerations for measurement-based care in the Canadian Armed Forces.

Journal of military, veteran and family health·2026

Rigor is not readiness: The PERL framework for evidence-based policy.

Science (New York, N.Y.)·2026

Exploring Australian Health Promotion Practitioners' Awareness, Understanding and Application of Theories of the Policy Process in Health Promotion Practice: A Qualitative Study.

Health promotion perspectives·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us